SARS-CoV-2 infection in a X-linked agammaglobulinemia adolescent: An immunological approach to treatment

Pediatr Allergy Immunol. 2023 Mar;34(3):e13921. doi: 10.1111/pai.13921.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Agammaglobulinemia* / complications
  • Agammaglobulinemia* / diagnosis
  • Agammaglobulinemia* / therapy
  • COVID-19*
  • Genetic Diseases, X-Linked* / complications
  • Genetic Diseases, X-Linked* / diagnosis
  • Genetic Diseases, X-Linked* / therapy
  • Humans
  • SARS-CoV-2

Supplementary concepts

  • Bruton type agammaglobulinemia